A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer
Clinical trial NCT02172911 · COMPLETED
Trial details
- NCT number
- NCT02172911
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-06
- Primary completion
- 2017-09-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.